FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Fate Therapeutics
Fate Therapeutics
Cancer Research UK
Institut Paoli-Calmettes
Fate Therapeutics
NKGen Biotech, Inc.
Jonsson Comprehensive Cancer Center